Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer

奈达铂 多西紫杉醇 医学 内科学 氟尿嘧啶 化疗 肿瘤科 食管癌 白细胞减少症 中性粒细胞减少症 养生 癌症 外科 顺铂
作者
Makoto Sohda,Keigo Hara,KENGO KURIYAMA,K. Tateno,SHINTARO UCHIDA,Takayoshi Watanabe,Yuta Shibasaki,HIDEYUKI SAITO,Nobuhiro Nakazawa,Akihiko Sano,Makoto Sakai,TAKEHIKO YOKOBORI,Hiroomi Ogawa,Ken Shirabe,Hiroshi Saeki
出处
期刊:Anticancer Research [Anticancer Research USA Inc.]
卷期号:44 (3): 1309-1315
标识
DOI:10.21873/anticanres.16926
摘要

Background/Aim: Chemotherapy and immunotherapy have been recently developed as potentially useful first-line treatments for unresectable, advanced, or recurrent esophageal cancer. We performed a retrospective study of the therapeutic effectiveness of triplet chemotherapy with docetaxel, nedaplatin, and 5-fluorouracil therapy for advanced, recurrent, and unresectable advanced esophageal cancer at our hospital and compared the regimen's results with those of current and possible future treatment options. Patients and Methods: The study cohort comprised 101 patients who received docetaxel, nedaplatin, and 5-fluorouracil for advanced or recurrent esophageal cancer at Gunma University from May 2008 to December 2017. We retrospectively evaluated the results of this combination chemotherapy and postulated future treatment strategies. Results: The overall response and disease control rates, the latter including stable disease, for docetaxel, nedaplatin, and 5-fluorouracil were 33.6% and 61.4%, respectively. The median overall survival and progression-free survival were 12.26 months and 5.1 months, respectively. In patients with recurrence, the median overall and progression-free survivals were 14.97 months (449 days) and 5.1 months (152 days), respectively. No study patients developed acute kidney injury and there were no treatment-related deaths. However, leukopenia and neutropenia were frequent hematologic toxicities. Conclusion: Treatment with docetaxel, nedaplatin, and 5-fluorouracil for advanced or recurrent esophageal cancer is particularly useful for recurrent cases and has the advantage of not causing severe renal dysfunction.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DQY发布了新的文献求助10
1秒前
森森完成签到,获得积分10
2秒前
一丁点可爱完成签到,获得积分10
2秒前
3秒前
王嘉尔完成签到 ,获得积分10
6秒前
隔壁巷子里的劉完成签到 ,获得积分10
6秒前
6秒前
wilson发布了新的文献求助200
6秒前
6秒前
sun完成签到 ,获得积分10
7秒前
7秒前
无花果应助woodenfish采纳,获得10
8秒前
韦老虎发布了新的文献求助10
8秒前
小马甲应助11采纳,获得10
8秒前
健壮宛凝发布了新的文献求助10
8秒前
xixo发布了新的文献求助10
10秒前
10秒前
10秒前
奔波儿灞完成签到,获得积分20
11秒前
思源应助来一笼小汤包采纳,获得10
12秒前
幽默从安发布了新的文献求助10
13秒前
YOUZI完成签到,获得积分10
13秒前
eason应助hkh采纳,获得10
14秒前
eason应助hkh采纳,获得10
14秒前
14秒前
hhhhmmmn完成签到,获得积分10
15秒前
坚定的安白完成签到,获得积分10
15秒前
cherish完成签到,获得积分10
16秒前
王嘉尔发布了新的文献求助10
17秒前
17秒前
凡0727完成签到 ,获得积分10
18秒前
夏青荷发布了新的文献求助10
19秒前
ding应助好大一只小坏蛋采纳,获得10
20秒前
20秒前
NexusExplorer应助默默海露采纳,获得10
20秒前
端庄的如花完成签到 ,获得积分10
21秒前
wam完成签到,获得积分10
21秒前
西瓜不嘻嘻完成签到,获得积分10
21秒前
静爸完成签到,获得积分20
21秒前
happyboy2008完成签到 ,获得积分10
21秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Structural Load Modelling and Combination for Performance and Safety Evaluation 1000
Conference Record, IAS Annual Meeting 1977 820
電気学会論文誌D(産業応用部門誌), 141 巻, 11 号 510
Typology of Conditional Constructions 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3571673
求助须知:如何正确求助?哪些是违规求助? 3142191
关于积分的说明 9446165
捐赠科研通 2843609
什么是DOI,文献DOI怎么找? 1562951
邀请新用户注册赠送积分活动 731458
科研通“疑难数据库(出版商)”最低求助积分说明 718557